Advertisement

Document › Details
PepGen Ltd.. (3/27/18). "Press Release: PepGen Has Launched".
![]() |
Region | Oxford, Oxfordshire |
Country | United Kingdom (GB) | |
![]() |
Organisation | PepGen Ltd. |
Today | PepGen (Group) | |
Group | PepGen (Group) | |
Organisation 2 | Oxford Sciences Innovation plc (OSI) | |
Group | University of Oxford | |
![]() |
Product | EDO technology (enhanced delivery oligonucleotides) (PepGen) |
Product 2 | venture capital | |
![]() |
Index term | PepGen–Univ Oxford: investment, 201803– seed investment £4.5m from Oxford Sciences Innovation |
![]() |
Person | Godfrey, Caroline (PepGen 201912 CEO + Academic Founder) |
Person 2 | Campion, Giles (Prosensa 201309 CMO) | |
On 26th March 2018 PepGen, a biotech company focused on the peptide-mediated delivery of nucleic acids, was spun out from the University of Oxford (OU) and the Medical Research Council (MRC). The intellectual property underpinning PepGen’s technology platform was developed through a decade-long collaboration between Professor Matthew Wood (OU) and Dr Michael Gait (MRC). The company’s co-founders are Dr Caroline Godfrey and Dr Giles Campion, with Dr Godfrey taking the role of CEO.
PepGen has received an initial £2.5M of seed funding from Oxford Sciences Innovation (OSI), and will focus on the pre-clinical validation of the company’s peptide delivery platform before building towards the commercialisation of this technology across a broad range of indications. These activities will be guided and supported by PepGen’s founding Board of Directors, Dr Wood, Dr Godfrey and Dr Andrew Mclean (OSI).
Record changed: 2021-02-07 |
Advertisement

More documents for PepGen (Group)
- [1] PepGen Ltd.. (2/4/21). "Press Release: PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer". Boston, MA & Oxford....
- [2] PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford....
- [3] PepGen Ltd.. (1/30/20). "Press Release: PepGen Joins Forces with Researchers to Tackle Brain Comorbidity in DMD"....
- [4] PepGen Ltd.. (2/1/19). "Press Release: PepGen’s £1.6M Grant from Innovate UK Has Commenced"....
- [5] PepGen Ltd.. (11/23/18). "Press Release: Damian Marron Appointed as PepGen’s Chairman of the Board"....
- [6] PepGen Ltd.. (11/2/18). "Press Release: PepGen Receives a £1.6M Grant from Innovate UK"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
» top